_edited.png)
Biomimicry and
Health & Pharma
Rethinking health through principles proven by living beings
A healthcare sector undergoing rapid change, between innovations and challenges
The healthcare sector is experiencing continuous expansion, with spending potentially exceeding 12% of global GDP by 2040 , illustrating the scale of investment required to support medical and technological advancements. This growth is driven by the rise of biotechnology, personalized medicine, and digital innovations , profoundly transforming patient care and prevention strategies.
In this context, the innovation challenges are numerous and extend far beyond digital technology. While artificial intelligence is revolutionizing diagnostics and predictive medicine, other major technical challenges are emerging. Improving implants and prostheses, developing more resistant and biocompatible biomaterials , and optimizing measurement and detection devices are essential to ensuring more precise and personalized care.
Faced with these changes, the healthcare industry must combine innovation and resilience while adhering to an increasingly stringent regulatory framework. Public research institutions, biotechnology companies, pharmaceutical companies, Medtech firms—all these players must meet heightened demands for safety, efficacy, and ethics , particularly through more advanced clinical trials and more rigorous regulatory validation. At the same time, the sustainability of medical equipment and the management of healthcare waste are becoming growing concerns. In this constantly evolving environment, the exploration of new materials, the development of advanced medical devices, and the optimization of care strategies are essential drivers for ensuring innovation and improving access to high-quality treatments.
Biomimicry presents a major technological opportunity for the healthcare sector:
For 3.8 billion years , nature has been developing solutions of unparalleled precision and efficiency , optimized to adapt to complex environments. Drawing inspiration from these proven mechanisms, biomimicry is revolutionizing healthcare by rethinking medical devices, biocompatible materials, and treatment strategies , offering sustainable, high-performance innovations tailored to the medical challenges of tomorrow.
The fight against hospital-acquired infections, a key challenge for the sector, directly benefits from nature-inspired solutions. Nepenthes alata , a carnivorous plant with ultra-slippery walls to trap its prey, has inspired the development of medical tubes with hyper-slippery internal surfaces, preventing bacterial adhesion and thus reducing the risk of infection. Similarly, shark skin, covered with natural microstructures that limit the adhesion of marine organisms, has inspired the creation of antifouling surfaces for medical equipment, offering an alternative to chemical antibacterial treatments.
Biomimicry is also transforming healthcare delivery by drawing inspiration from the adaptive strategies of living organisms. Mosquitoes , capable of biting undetected thanks to the specific structure of their proboscis, have inspired the development of painless microneedle patches , facilitating drug administration while reducing patient pain and stress. Furthermore, mussels, whose adhesive proteins withstand the harshest marine environments, have inspired the development of biocompatible adhesives capable of replacing surgical sutures and bonding effectively in moist environments—a valuable advancement for reconstructive medicine.
Finally, nature also provides major innovations in the field of diagnostics. The mantis shrimp , capable of perceiving polarized light thanks to a unique optical system, has inspired an oncology detection camera based on light polarization, allowing for the identification of cancer cells with increased precision.
Bionnov, a French expert in biomimicry, supports players in the health sector in transforming these natural innovations into concrete solutions, helping to shape a more efficient, precise and sustainable medicine.
